NCT00590824 2019-11-21
Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma
University of Wisconsin, Madison
Phase 2 Completed
Clinical Trials
3 trialsNCT01334515 2019-10-21
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Children's Oncology Group
Phase 2 Completed
NCT00082758 2015-02-12
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Children's Oncology Group
Phase 2 Completed